TY - JOUR
T1 - A minimal cytoplasmic subdomain of the erythropoietin receptor mediates p70 S6 kinase phosphorylation
AU - Zhang, Min Ying
AU - Barber, Dwayne L.
AU - Alessi, Dario R.
AU - Bell, Laurie L.
AU - Stine, Carol
AU - Nguyen, Melody H.H.
AU - Beattie, Bryan K.
AU - Cheung, Joseph Y.
AU - Miller, Barbara A.
N1 - Funding Information:
This work was supported by grants from the National Institutes of Health DK 46778 (B.A.M.), M01 RR10732 (GCRC Grant), F32 DK 09790 (M.-Y.Z.), and HL 58672 (J.Y.C.); from the Medical Research Council of Canada MT-13612 (D.L.B.); and from the Four Diamonds Fund. D.L.B. is a National Cancer Institute of Canada Research Scientist. We thank Dr. Kathleen Mulder for generous sharing of equipment and Tina Eberly and Julie A. Brosius for careful preparation of the manuscript.
PY - 2001
Y1 - 2001
N2 - Objective. Erythropoietin (EPO) is a lineage-restricted growth factor that is required for erythroid proliferation and differentiation. EPO stimulates the phosphorylation and activation of p70 S6 kinase (p70 S6K), which is required for cell cycle progression. Here, the minimal cytoplasmic domains of the EPO receptor (EPO-R) required for p70 S6K activation were determined. Materials and Methods. Ba/F3 cells were stably transfected with wild-type (WT) EPO-R or EPO-R carboxyl-terminal deletion mutants, designated by the number of amino acids deleted from the cytoplasmic tail (-99, -131, -221). Transfected cells were growth factor deprived and then stimulated with EPO. p70 S6K, JAK2, IRS-2, and ERK1/2 phosphorylation/activation were examined. The ability of transfected 3-phosphoinositide-dependent protein kinase 1 (PDK1) to reconstitute p70 S6K phosphorylation in EPO-R mutants also was determined.ResultsPhosphorylation and activation of p70 S6K, JAK2, IRS-2, and ERK1/2 in Ba/F3 cells transfected with EPO-R-99 or EPO-R-99Y343F were similar to WT EPO-R. In contrast, EPO-dependent p70 S6K phosphorylation/activation, as well as IRS-2 and ERK1/2 phosphorylation, were minimal or absent in cells transfected with EPO-R-131 or EPO-R-221. JAK2 phosphorylation was reduced significantly in cells transfected with EPO-R-131 and abolished with EPO-R-221. To examine the role of PDK1, a kinase known to phosphorylate p70 S6K, Ba/F3 EPO-R-131 cells were transiently transfected with PDK1. WT constitutively active PDK1 restored p70 S6K phosphorylation in Ba/F3 EPO-R-131 cells but not in Ba/F3 EPO-R-221 cells. Conclusions. The results demonstrate that a minimal cytoplasmic subdomain of the EPO-R extending between -99 and -131 is required for p70 S6K phosphorylation and activation. The results also demonstrate that PDK1 is a critical component in this signaling pathway, which requires the presence of domains between -131 and -221 for its activation of p70 S6K.
AB - Objective. Erythropoietin (EPO) is a lineage-restricted growth factor that is required for erythroid proliferation and differentiation. EPO stimulates the phosphorylation and activation of p70 S6 kinase (p70 S6K), which is required for cell cycle progression. Here, the minimal cytoplasmic domains of the EPO receptor (EPO-R) required for p70 S6K activation were determined. Materials and Methods. Ba/F3 cells were stably transfected with wild-type (WT) EPO-R or EPO-R carboxyl-terminal deletion mutants, designated by the number of amino acids deleted from the cytoplasmic tail (-99, -131, -221). Transfected cells were growth factor deprived and then stimulated with EPO. p70 S6K, JAK2, IRS-2, and ERK1/2 phosphorylation/activation were examined. The ability of transfected 3-phosphoinositide-dependent protein kinase 1 (PDK1) to reconstitute p70 S6K phosphorylation in EPO-R mutants also was determined.ResultsPhosphorylation and activation of p70 S6K, JAK2, IRS-2, and ERK1/2 in Ba/F3 cells transfected with EPO-R-99 or EPO-R-99Y343F were similar to WT EPO-R. In contrast, EPO-dependent p70 S6K phosphorylation/activation, as well as IRS-2 and ERK1/2 phosphorylation, were minimal or absent in cells transfected with EPO-R-131 or EPO-R-221. JAK2 phosphorylation was reduced significantly in cells transfected with EPO-R-131 and abolished with EPO-R-221. To examine the role of PDK1, a kinase known to phosphorylate p70 S6K, Ba/F3 EPO-R-131 cells were transiently transfected with PDK1. WT constitutively active PDK1 restored p70 S6K phosphorylation in Ba/F3 EPO-R-131 cells but not in Ba/F3 EPO-R-221 cells. Conclusions. The results demonstrate that a minimal cytoplasmic subdomain of the EPO-R extending between -99 and -131 is required for p70 S6K phosphorylation and activation. The results also demonstrate that PDK1 is a critical component in this signaling pathway, which requires the presence of domains between -131 and -221 for its activation of p70 S6K.
UR - http://www.scopus.com/inward/record.url?scp=0035065931&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035065931&partnerID=8YFLogxK
U2 - 10.1016/S0301-472X(00)00681-0
DO - 10.1016/S0301-472X(00)00681-0
M3 - Article
C2 - 11301183
AN - SCOPUS:0035065931
SN - 0301-472X
VL - 29
SP - 432
EP - 440
JO - Experimental Hematology
JF - Experimental Hematology
IS - 4
ER -
